STUDY OF DRUGS IN PATIENTS OF PAINFUL DIABETIC NEUROPATHY
Phase 4
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2019/08/020810
- Lead Sponsor
- Dr Chetna Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients more than 18 years of age with type 2 diabetes mellitus with signs and symptoms of painful diabetic neuropathy
Exclusion Criteria
type 1 diabetes mellitus
other reasons known to cause neuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study the effect of methylcobalamin, combination of methylcobalamin with pregabalin and methylcobalamin with duloxetine in patients with painful diabetic neuropathy.Timepoint: outcome will be assessed at the end of three month period from the day of recruitment
- Secondary Outcome Measures
Name Time Method 2.To compare safety, tolerability and economic implications of all the three study groups.Timepoint: monthly for 3 months